Date:5/17/2010

4,553,560 3,868,577 Taxes payable 7,519,268 8,774,079 Investment payable 2,195,365 2,195,365 Total current liabilities 50,374,496 51,118,179 OTHER LIABILITIES: Other payable - land use right 323,390 323,687 Notes payable, net of discount of $7,325,349 and $8,464,380 as of March 31, 2010 and December 31, 2009, respectively 174,651 89,760 Derivative liability - conversion option 15,275,245 19,960,145 Fair value of derivative instruments 9,177,262 12,701,262 Total other liabilities 24,950,548 33,074,854 Total liabilities 75,325,044 84,193,033 COMMITMENTS AND CONTINGENCIES EQUITY: Common stock, $0.0001 par value, 100,000,000 shares authorized, 23,500,803 and 23,056,442 shares issued and outstanding at March 31, 2010 and December 31, 2009, respectively 2,349 2,305 Additional paid-in-capital 28,024,808 22,517,077 Statutory reserves 19,831,853 17,414,769 Retained earnings 13,491,161 5,302,605 Accumulated other comprehensive income 5,272,137 5,276,791 Total shareholders' equity 66,622,308 50,513,547 NONCONTROLLING INTEREST 32,445,226 33,129,764 Total equity 99,067,534 83,643,311 Total liabilities and equity $174,392,578 $167,836,344 CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH
'/>"/>

SOURCE China Biologic Products, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine technology :

1. China Sky One Medicals CEO Receives Award For "Leadership Excellence In Innovation"
2. China Sky One Medical to Attend Investment Conferences in May
3. China Biologic Products to Build Two New Plasma Stations in Shandong Province
4. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
5. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
6. China Pharma Holdings, Inc. Announces May Investor Conference Participation
7. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
8. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
9. China Pharma Holdings, Inc. Retains CCG Investor Relations
10. China Medical Technologies to Participate in Investor Conferences in May and June 2010
11. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen